GLP-1 Medications Show Little Effect on Cancer, Study Shows
WEDNESDAY, Dec. 10, 2025 A new study suggests popular GLP-1 drugs, like Ozempic and Zepbound, may not lower cancer risk as some had hoped.Researchers analyzed 4
Global market analysis for whey hydrolysates in medical nutrition drinks. Forecast to 2035 with CAGR, key drivers, regional outlook, and competitive landscape. Post Views: 2
A coalition of states filed a lawsuit Monday challenging a Trump administration effort to impose certain conditions on billions of dollars for key federal nutrition programs from the Department of Agriculture. The
Ka’Chava founder Simon Malone turned a wellness retreat epiphany into a whole-body nutrition brand that stayed DTC for a decade before making a disciplined retail move. Post Views: 3
A new study published in ASN’s The Journal of Nutrition suggests that levels of a hormone called asprosin may predict weight changes in certain postmenopausal Post Views: 1